Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

NeuroOne Medical Technologies Corporation (NMTC) vs SINTX TECHNOLOGIES, INC. (SINT)

NeuroOne Medical Technologies Corporation and SINTX TECHNOLOGIES, INC. are both Medical Devices companies. NeuroOne Medical Technologies Corporation and SINTX TECHNOLOGIES, INC. are of similar size ($12.5M and $12.1M). NeuroOne Medical Technologies Corporation grew revenue faster over the last twelve months: −1.67% against −28.5%. NeuroOne Medical Technologies Corporation has the higher net margin (−78.6% vs −1,423.0%) and the higher return on invested capital (−287.1% vs −548.1%). Across the 18 metrics below, NeuroOne Medical Technologies Corporation leads on 16 and SINTX TECHNOLOGIES, INC. on 2.

Valuation

Metric NMTC SINT Medical Devices median
P/E n/m n/m 22.18
P/S 1.22 6.85 2.70
P/B 3.06 1.89 2.46
Price to free cash flow n/m n/m 22.53
EV/EBITDA n/m n/m 11.78
EV/Sales 1.00 5.02 2.38
Earnings yield (67.67%) (279.01%) (8.22%)
Free cash flow yield (62.16%) (113.93%) (7.80%)

Profitability

Metric NMTC SINT Medical Devices median
Gross margin 55.65% 52.86% 56.01%
Operating margin (83.43%) (884.81%) (15.03%)
Net margin (78.63%) (1,423.01%) (20.40%)
Free cash flow margin (75.63%) (777.14%) (7.24%)
Return on equity (124.66%) (429.26%) (15.32%)
Return on assets (87.56%) (192.88%) (19.72%)
Return on invested capital (287.08%) (548.06%) (10.33%)

Growth

Metric NMTC SINT Medical Devices median
Revenue growth (TTM) (1.67%) (28.53%) 8.80%
EPS growth (last fiscal year) 80.43% 59.45% —
Revenue growth, 5-year CAGR 44.41% 11.38% 15.23%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NMTC SINT Medical Devices median
Debt to equity 0.00 0.02 0.07
Current ratio 2.84 2.36 2.50
Net debt to EBITDA 1.74 0.41 0.49

Dividend

Metric NMTC SINT Medical Devices median
Dividend yield — — 0.94%
Payout ratio 0.00 0.00 0.00

Size

Metric NMTC SINT Medical Devices median
Market cap 12.11m 12.46m 172.91m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack